Results 81 to 90 of about 188,070 (188)

Anti-tumor targeted drug delivery systems mediated by aminopeptidase N/CD13

open access: yes, 2011
Aminopeptidase N (APN)/CD13 is a transmembrane glycoprotein, which is overexpressed on tumor neovascular endothelial cells and most tumor cells, where it plays an important role in tumor angiogenesis.
Bin Wang, Xun Wang, Qiang Zhang
core   +1 more source

Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation

open access: yesHaematologica, 2004
BACKGROUND AND OBJECTIVES: Hematopoietic progenitor cells (HPC) circulate in the peripheral blood (PB) before and after engraftment following autologous or allogeneic peripheral blood stem cell transplantation (PBSCT), although the characteristics of ...
C Albo   +4 more
doaj  

Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells

open access: yesHaematologica, 2003
BACKGROUND AND OBJECTIVES: Mesenchymal stem cells (MSC) and neural progenitor cells (NPC) are pluripotent cells. The former can give rise to myocytes, chondrocytes, adipocytes, and osteogenic cells, while the latter can give rise to astrocytes, neurons ...
W Vogel   +5 more
doaj  

Immunophenotypic study of acute leukemia by flow cytometry at BPKMCH.

open access: yesJournal of Pathology of Nepal, 2013
Background: Immunophenotyping of acute leukemia is one of the most important clinical applications of fl ow cytometry. The aim of this study was to determine the immunophenotyping profi le of acute leukemia, by means of a fl ow cytometric method, using ...
S Shrestha   +5 more
doaj   +1 more source

Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells [PDF]

open access: yes, 2007
Background Aminopeptidase N (APN/CD13), a 150-kDa metalloprotease, is a multifunctional cell surface aminopeptidase with ubiquitous expression. Recent studies have suggested that APN/CD13 plays an important role in tumor progression of several human ...
Kajiyama Hiroaki   +13 more
core   +2 more sources

Simultaneous expression of CD13, CD22 and CD25 is related to the expression of FcεR1 in non-lymphoid leukemia [PDF]

open access: yes
Like CD19 or CD56, CD22 in non-lymphoid leukemia has been considered an aberrantly expressed antigen. CD22 had been believed to be restricted to B lymphoid, however, it was also found to be expressed in human basophils.
7233   +15 more
core   +1 more source

High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources

open access: yesStem Cell Research & Therapy, 2018
Background Mesenchymal stromal cells (MSC) are a heterogeneous population of multipotent progenitors used in the clinic because of their immunomodulatory properties and their ability to differentiate into multiple mesodermal lineages.
Eliana Amati   +8 more
doaj   +1 more source

Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma

open access: yes, 2018
Angiogenesis is a crucial factor in the progression of malignant pleural mesothelioma (MPM) and antiangiogenic strategies might be effective against MPM.
Shin Akita   +14 more
core   +1 more source

Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?

open access: yesİstanbul Medical Journal, 2017
Introduction: Acute myeloid leukemia (AML) is an aggressive clonal myeloid neoplasm that causes the accumulation of myeloblasts in blood and bone marrow.
Hava Üsküdar Teke   +5 more
doaj   +1 more source

Aislamiento y caracterización de células “stem” mesenquimales de médula ósea humana según criterios de la Sociedad Internacional de Terapia Celular

open access: yesUniversitas Scientiarum, 2010
Isolation and characterization of mesenchymal stem cells from human bone marrow according to the criteria of the InternationalSociety for Cellular Therapy.
Jose Alejandro Aristizabal-Castellanos   +2 more
doaj  

Home - About - Disclaimer - Privacy